Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy
Chayakrit Krittanawong, Muzamil Khawaja, Robert S. Rosenson, Christopher I. Amos, Vijay Nambi, Carl J. Lavie, Salim S. Virani
Topics & Concepts
Mendelian randomizationPCSK9PharmacogenomicsMedicineCandidate geneContext (archaeology)PopulationLDL receptorDiseaseBioinformaticsAlleleFamilial hypercholesterolemiaGeneticsGeneLipoproteinPharmacologyInternal medicineCholesterolBiologyGenetic variantsGenotypePaleontologyEnvironmental healthLipoproteins and Cardiovascular HealthPharmaceutical Economics and Policy